Write this review article MAINLY with the articles I provided (see attachment). If you need additional source, make sure it is primary research article, i.e. not a review article. The paper should meet master’s level and no AI content is allowed.
Here is the outline which I hope you can follow:
Introduction
- Brief introduction to neurodevelopmental disorders (NDDs) (e.g., Autism Spectrum Disorder (ASD), Intellectual Disability (ID), and Schizophrenia (SCZ)).
- Importance of genetic factors in NDDs.
- Introduction to the concept of de novo mutations.
- Overview of the significance of synaptic genes in neurodevelopment.
- Objective of the review: To explore the impact of de novo mutations in ‘synaptic’ genes on neurodevelopmental disorders.
Definition and Scope of ‘Synaptic’ Genes
- Definition of synaptic genes (genes involved in synaptic function and structure).
- Broader scope: Genes not exclusively synaptic but involved in neuronal signaling and communication.
- Examples of key ‘synaptic’ genes (e.g., SHANK3, SYNGAP1, NRXN1).
Mechanisms of Synaptic Function and Neurodevelopment
- Overview of synapse formation, maintenance, and plasticity.
- Role of synaptic genes in early brain development and neuronal communication.
- Impact of synaptic dysfunction on neurodevelopment.
De Novo Mutations in ‘Synaptic’ Genes
- Explanation of de novo mutations and their occurrence.
- Methods for identifying de novo mutations (e.g., whole-exome sequencing, whole-genome sequencing).
- Examples of de novo mutations in key ‘synaptic’ genes associated with NDDs.
Impact of De Novo Mutations on Synaptic Function
- How de novo mutations affect synaptic structure and function.
- Case studies or examples of specific mutations and their impact on synaptic genes (e.g., SHANK3 mutations leading to Phelan-McDermid syndrome).
Correlation Between Synaptic Gene Mutations and NDD Phenotypes
- Studies linking specific de novo mutations to clinical phenotypes.
- Variability in phenotypic expression and factors influencing this variability.
- Comparison of phenotypic outcomes in different NDDs (ASD, ID, SCZ).
Therapeutic Implications and Future Directions
- Current therapeutic approaches targeting synaptic dysfunction (e.g., pharmacological interventions, gene therapy).
- Potential for personalized medicine based on genetic findings.
- Future research directions and the importance of continued exploration of de novo mutations in synaptic genes.
Conclusion